SPOTLIGHT -
Unmet Needs and the Future of Kidney Cancer
Drs Tom Powles and Brian Shimkus muse on the unmet needs of kidney cancers and treatments on the horizon to look forward to.
Treatment Approaches for Good Risk Patients with Renal Cell Carcinoma
A discussion on how patient risk groups play into deciding on the appropriate treatment for renal cell carcinoma.
Choosing a Combination Therapy for Renal Cell Carcinoma Before and After CLEAR Data
Brian Shimkus, MD, discusses how he chose between RCC combination therapies before CLEAR trial data, and how the data influences his decisions now.
Dose Reductions and Treatment Breaks on Lenvatinib Therapy
Dr Brian Shimkus describes how he doses lenvatinib for renal cell carcinoma treatment.
Choosing Therapies for Patients with Advanced Renal Cell Carcinoma
A physician explains why he doesn’t believe there is a “typical” patient and why advanced RCC therapies must be tailored to each case.
A Physician’s Take on the CLEAR Trial Data
Brian Shimkus, MD, shares his opinion of data on lenvatinib and pembrolizumab from the CLEAR trial.
